Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (53)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacasse, Y.
Right arrow Articles by Goldstein, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacasse, Y.
Right arrow Articles by Goldstein, R. S.
(Chest. 1999;116:306-313.)
© 1999 American College of Chest Physicians

Trends in the Epidemiology of COPD in Canada, 1980 to 1995*

Yves Lacasse, MD, MSc; Dina Brooks, PhD; Roger S. Goldstein, MB, ChB, FCCP, and for the COPD and Rehabilitation Committee of the Canadian Thoracic Society

* From the Centre de Pneumologie (Dr. Lacasse), Hôpital Laval, Ste-Foy, Québec, Canada; and the Department of Physical Therapy (Drs. Brooks and Goldstein), and the Department of Medicine (Dr. Goldstein), University of Toronto, Ontario, Canada.

Correspondence to: Yves Lacasse, MD, MSc, Centre de Pneumologie, Hôpital Laval, 2725 Chemin Ste-Foy, Ste-Foy, P. Québec G1V 4G5, Canada; e-mail: lacassey{at}videotron.ca

Purpose: To describe trends in the epidemiology of COPD in Canada from 1980 to 1995, in terms of perceived prevalence, mortality, and hospital morbidity.

Data sources: We limited the analysis to data related to chronic bronchitis, emphysema, or chronic airway obstruction not classified elsewhere, and excluded asthma (Ninth International Classification of Diseases, codes 490 to 492 and 496). The perceived prevalence rate of COPD was derived from the 1994–1995 National Health Survey. Mortality and hospital morbidity data (from 1980 to 1995) were obtained from the Health Statistics Division of Statistics Canada.

Results: From the National Health Survey, it was estimated that 750,000 Canadians had chronic bronchitis or emphysema diagnosed by a health professional. Prevalence rates were the following: ages 55 to 64 years, 4.6%; ages 65 to 74 years, 5.0%; >= 75 years, 6.8%. From 1980 to 1995, the total number of deaths from COPD increased from 4,438 to 8,583. Although the age-standardized mortality rate remained stable throughout this period in men (around 45/100,000 population), it doubled in women (8.3/100,000 in 1980 to 17.3/100,000 in 1995). There were 55,782 hospital separations in 1993–1994 with COPD as the primary discharge diagnosis (compared to 42,102 in 1981–1982). In people aged >= 65 years, the age-specific hospital separation rate increased over this period, especially in women >= 75 years (from 504/100,000 to 1,033/100,000). The average in-hospital length of stay was 9.6 days in 1981–1982 and 8.3 days in 1993–1994.

Conclusion: COPD represents a major health issue in Canada and will likely remain so for decades. Physician and non-physician health professionals who provide health care, as well as those who fund it must actively encourage approaches for primary and secondary prevention of this condition as well as approaches shown to be effective in addressing its associated impairment, disability, and handicap.

Key Words: COPD • epidemiology • morbidity • mortality • prevalence rate




This article has been cited by other articles:


Home page
ChestHome page
W. C. Tan and T. P. Ng
COPD in Asia: Where East Meets West
Chest, February 1, 2008; 133(2): 517 - 527.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C Fuhrman, E Jougla, J Nicolau, D Eilstein, and M-C Delmas
Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis
Thorax, November 1, 2006; 61(11): 930 - 934.
[Abstract] [Full Text] [PDF]


Home page
Clin Nurs ResHome page
J. Bissonnette, J. Logan, B. Davies, and I. D. Graham
Methodological Issues Encountered in a Study of Hospitalized COPD Patients
Clin Nurs Res, February 1, 2005; 14(1): 81 - 97.
[Abstract] [PDF]


Home page
CMAJHome page
C. R. Dormuth, M. Maclure, K. Bassett, C. Jauca, C. Whiteside, and J. M. Wright
Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial
Can. Med. Assoc. J., October 26, 2004; 171(9): 1057 - 1061.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. A. El-Kassimi and N. A. Hanania
Differentiating Asthma and COPD Patients
Chest, August 1, 2004; 126(2): 653 - 655.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E J van Dijk, S E Vermeer, J C de Groot, J van de Minkelis, N D Prins, M Oudkerk, A Hofman, P J Koudstaal, and M M B Breteler
Arterial oxygen saturation, COPD, and cerebral small vessel disease
J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 733 - 736.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
N. Tzanakis, U. Anagnostopoulou, V. Filaditaki, P. Christaki, and N. Siafakas
Prevalence of COPD in Greece
Chest, March 1, 2004; 125(3): 892 - 900.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. H. Groenewegen, A. M.W.J. Schols, and E. F.M. Wouters
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD
Chest, August 1, 2003; 124(2): 459 - 467.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. Lesauskaite
Age-Related Trends in Mortality From COPD in Lithuania, 1989 to 1998
Chest, July 1, 2003; 124(1): 90 - 93.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. J. Halbert, S. Isonaka, D. George, and A. Iqbal
Interpreting COPD Prevalence Estimates: What Is the True Burden of Disease?
Chest, May 1, 2003; 123(5): 1684 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N. Jakeways, T. McKeever, S.A. Lewis, S.T. Weiss, and J. Britton
Relationship between FEV1 reduction and respiratory symptoms in the general population
Eur. Respir. J., April 1, 2003; 21(4): 658 - 663.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. Brooks, B. Krip, S. Mangovski-Alzamora, and R.S. Goldstein
The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease
Eur. Respir. J., July 1, 2002; 20(1): 20 - 29.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
K. Schwartzman, G. Duquette, M. Zaoude, M.-J. Dion, M.-A. Lagace, J. Poitras, and M. G. Cosio
Respiratory day hospital: a novel approach to acute respiratory care
Can. Med. Assoc. J., October 1, 2001; 165(8): 1067 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. D. SIN and J. V. TU
Inhaled Corticosteroids and the Risk of Mortality and Readmission In Elderly Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 580 - 584.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
Y. Lacasse, I. Ferreira, D. Brooks, T. Newman, and R. S. Goldstein
Critical Appraisal of Clinical Practice Guidelines Targeting Chronic Obstructive Pulmonary Disease
Arch Intern Med, January 8, 2001; 161(1): 69 - 74.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. S. Pena, M. Miravitlles, R. Gabriel, C. A. Jimenez-Ruiz, C. Villasante, J. F. Masa, J. L. Viejo, and L. Fernandez-Fau
Geographic Variations in Prevalence and Underdiagnosis of COPD : Results of the IBERPOC Multicentre Epidemiological Study
Chest, October 1, 2000; 118(4): 981 - 989.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.